Autopsy report · NCT02233829

Dopamine Rhythms in Health and Addiction

“No enrollment, delay with drug availability.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Sponsor type

US National Institutes of Health

Conditions

Cocaine Abuse

Interventions

Brain Dopamine Reactivity; Brain Dopamine Receptor

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility
  “No further patient enrollment” (75% match in meaning)
• Study of XL418 in Adults With Solid Tumors
  “Enrollment suspended due to low drug exposure.” (72% match in meaning)
• Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury
  “No enrollment.” (71% match in meaning)
• Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal
  “Lack of Patient Enrollment” (67% match in meaning)
• Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Endodontics
  “Manufacturer discontinued drug before any participants could be enrolled.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.